Clinical Evidence has an update on the management of Crohn’s disease. A very useful read considering the fact that it is a disease with rising number of cases. Here is a list of the recommendations which underwent changes:
- Aminosalicylates to maintain remission: Categorization changed from likely to be ineffective/harmful to likely to ber beneficial
- Fish Oil: Categorization unchanged to Unknown efficacy
Treatments which are listed under beneficial include:
- Oral corticosteroids to induce remission
Treatments which are likely to be beneficial include:
- Laparoscopic versus open ileocecal resection
- Methotrexate
- Infliximab to maintain remission
- Aminosalicylates to maintain remission after surgery
- Azathioprine/Mercaptopurine to maintain remission after surgery
- Enteral Nutrition [I did not know this prior to reading this review update! WOW! 🙂 ]
Scepticemia 
One thought on “Crohn’s Disease on Clinical Evidence, BMJ”